NCT01510340

Brief Summary

The purpose of this study is to evaluate the efficacy of an online virtual intervention in optimizing adherence to antiretroviral medication intake among Persons Living with HIV (PLHIV).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
217

participants targeted

Target at P25-P50 for phase_3 hiv

Timeline
Completed

Started Jan 2012

Longer than P75 for phase_3 hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2011

Completed
19 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 16, 2012

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

August 6, 2021

Status Verified

August 1, 2021

Enrollment Period

7.9 years

First QC Date

December 13, 2011

Last Update Submit

August 2, 2021

Conditions

Keywords

adherenceHIVantiretroviral therapytailored web intervention

Outcome Measures

Primary Outcomes (1)

  • Adherence

    Adherence will be evaluated through a self-administered questionnaire that was developed for and validated on the targeted population (Godin, Gagné, \& Naccache, 2003). The questionnaire comprises seven items that serve to determine how many times a person forgets to take his or her medication. The questionnaire's validity was demonstrated (sensitivity: 71 %; specificity: 72%; correct classification: 72%; odds ratio: 6.15) using immunologic (CD4 count) and virologic (viral load) parameters as validation criteria. Adherence is defined as the intake of at least 95% of prescribed tablets.

    6 months

Study Arms (2)

Web sites

NO INTERVENTION

Patients assigned to this arm are given a list of Web sites where they can collect information related to their condition at their leisure.

VIH-TAVIE

EXPERIMENTAL

Patients assigned to this arm must follow the four interactive computer sessions

Behavioral: VIH-TAVIE

Interventions

VIH-TAVIEBEHAVIORAL

The tailored virtual intervention is composed of four interactive computer sessions hosted by a virtual nurse who engages the PLHIV in a medication-intake self-management skills-learning process.

VIH-TAVIE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have to be under ART for at least six months¸
  • have internet access

You may not qualify if:

  • be pregnant
  • active IV drug user
  • actual diagnosis of psychiatric health problem

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

José Côté

Montreal, Quebec, H2X 0A9, Canada

Location

Related Publications (2)

  • Cote J, Rouleau G, Ramirez-Garcia MP, Auger P, Thomas R, Leblanc J. Effectiveness of a Web-Based Intervention to Support Medication Adherence Among People Living With HIV: Web-Based Randomized Controlled Trial. JMIR Public Health Surveill. 2020 Apr 20;6(2):e17733. doi: 10.2196/17733.

  • Cote J, Godin G, Gueheneuc YG, Rouleau G, Ramirez-Garcia P, Otis J, Tremblay C, Fadel G. Evaluation of a real-time virtual intervention to empower persons living with HIV to use therapy self-management: study protocol for an online randomized controlled trial. Trials. 2012 Oct 5;13:187. doi: 10.1186/1745-6215-13-187.

Related Links

Study Officials

  • José Côté, Ph.D.

    CRCHUM, Université de Montréal

    PRINCIPAL INVESTIGATOR
  • Gaston Godin, Ph.D.

    Laval University

    STUDY CHAIR
  • Yann-Gael Guéhéneuc, Ph.D.

    Polytechnique

    STUDY CHAIR
  • Cécile Tremblay, MD,Ph.D.

    CRCHUM

    STUDY CHAIR
  • Joanne Otis, Ph.D.

    Université du Québec a Montréal

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2011

First Posted

January 16, 2012

Study Start

January 1, 2012

Primary Completion

December 1, 2019

Study Completion

June 1, 2020

Last Updated

August 6, 2021

Record last verified: 2021-08

Locations